Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Published:2007-06 Issue:9580 Volume:369 Page:2161-2170
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Paavonen Jorma,Jenkins David,Bosch F Xavier,Naud Paulo,Salmerón Jorge,Wheeler Cosette M,Chow Song-Nan,Apter Dan L,Kitchener Henry C,Castellsague Xavier,de Carvalho Newton S,Skinner S Rachel,Harper Diane M,Hedrick James A,Jaisamrarn Unnop,Limson Genara AM,Dionne Marc,Quint Wim,Spiessens Bart,Peeters Pascal,Struyf Frank,Wieting Susan L,Lehtinen Matti O,Dubin Gary

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

2. Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer;Stanley;Br J Cancer,2007

3. The epidemiology of genital human papillomavirus infection;Trottier;Vaccine,2006

4. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update;Smith;Int J Cancer,2007

5. Epidemiologic classification of human papillomavirus types associated with cervical cancer;Muñoz;N Engl J Med,2003

Cited by 1067 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV vaccines induce trained immunity and modulate pro‐inflammatory cytokine expression in response to secondary Toll‐like receptor stimulations;Microbiology and Immunology;2023-12-17

2. Self−Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot−and−Mouth Disease Virus;Vaccines;2023-11-02

3. Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect;Infectious Agents and Cancer;2023-10-29

4. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females;Vaccine;2023-10

5. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages;Cancers;2023-09-19